annual EBITDA:
-$48.97M+$87.52M(+64.12%)Summary
- As of today (June 1, 2025), MIRM annual EBITDA is -$48.97 million, with the most recent change of +$87.52 million (+64.12%) on December 31, 2024.
- During the last 3 years, MIRM annual EBITDA has risen by +$16.79 million (+25.54%).
- MIRM annual EBITDA is now at all-time high.
Performance
MIRM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$4.00M+$10.73M(+72.85%)Summary
- As of today (June 1, 2025), MIRM quarterly EBITDA is -$4.00 million, with the most recent change of +$10.73 million (+72.85%) on March 31, 2025.
- Over the past year, MIRM quarterly EBITDA has increased by +$11.41 million (+74.05%).
- MIRM quarterly EBITDA is now -106.52% below its all-time high of $61.38 million, reached on December 31, 2021.
Performance
MIRM quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$37.56M+$11.41M(+23.31%)Summary
- As of today (June 1, 2025), MIRM TTM EBITDA is -$37.56 million, with the most recent change of +$11.41 million (+23.31%) on March 31, 2025.
- Over the past year, MIRM TTM EBITDA has increased by +$90.00 million (+70.56%).
- MIRM TTM EBITDA is now -57681.54% below its all-time high of -$65.00 thousand, reached on September 30, 2018.
Performance
MIRM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MIRM EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +64.1% | +74.0% | +70.6% |
| 3 y3 years | +25.5% | +87.7% | +26.6% |
| 5 y5 years | +6.2% | +81.1% | +44.1% |
MIRM EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +64.1% | at high | +94.2% | -22.2% | +75.7% |
| 5 y | 5-year | at high | +64.1% | -106.5% | +94.2% | -22.2% | +77.1% |
| alltime | all time | at high | +64.1% | -106.5% | +94.2% | <-9999.0% | +77.1% |
MIRM EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$4.00M(-72.8%) | -$37.56M(-23.3%) |
| Dec 2024 | -$48.97M(-64.1%) | -$14.73M(+246.9%) | -$48.97M(-19.2%) |
| Sep 2024 | - | -$4.25M(-70.9%) | -$60.62M(-17.5%) |
| Jun 2024 | - | -$14.58M(-5.4%) | -$73.47M(-42.4%) |
| Mar 2024 | - | -$15.41M(-41.6%) | -$127.55M(-6.5%) |
| Dec 2023 | -$136.49M(+11.1%) | -$26.38M(+54.2%) | -$136.49M(-3.1%) |
| Sep 2023 | - | -$17.10M(-75.1%) | -$140.84M(-8.8%) |
| Jun 2023 | - | -$68.66M(+182.0%) | -$154.37M(+34.4%) |
| Mar 2023 | - | -$24.35M(-20.8%) | -$114.83M(-6.5%) |
| Dec 2022 | -$122.85M(+86.8%) | -$30.73M(+0.3%) | -$122.85M(+299.6%) |
| Sep 2022 | - | -$30.63M(+5.2%) | -$30.74M(-25.7%) |
| Jun 2022 | - | -$29.12M(-10.1%) | -$41.37M(-19.2%) |
| Mar 2022 | - | -$32.38M(-152.7%) | -$51.18M(-22.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$65.77M(-35.7%) | $61.38M(-248.8%) | -$65.77M(-59.9%) |
| Sep 2021 | - | -$41.25M(+6.0%) | -$163.85M(+13.8%) |
| Jun 2021 | - | -$38.93M(-17.1%) | -$143.95M(+12.4%) |
| Mar 2021 | - | -$46.96M(+28.0%) | -$128.12M(+25.2%) |
| Dec 2020 | -$102.31M(+96.0%) | -$36.70M(+71.9%) | -$102.31M(+24.9%) |
| Sep 2020 | - | -$21.35M(-7.6%) | -$81.93M(+7.3%) |
| Jun 2020 | - | -$23.10M(+9.2%) | -$76.36M(+13.6%) |
| Mar 2020 | - | -$21.15M(+29.5%) | -$67.20M(+28.7%) |
| Dec 2019 | -$52.21M | -$16.33M(+3.5%) | -$52.21M(+45.5%) |
| Sep 2019 | - | -$15.78M(+13.1%) | -$35.88M(+77.9%) |
| Jun 2019 | - | -$13.95M(+126.5%) | -$20.17M(+224.1%) |
| Mar 2019 | - | -$6.16M(+9372.3%) | -$6.22M(+9472.3%) |
| Sep 2018 | - | -$65.00K | -$65.00K |
FAQ
- What is Mirum Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals annual EBITDA year-on-year change?
- What is Mirum Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Mirum Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals TTM EBITDA year-on-year change?
What is Mirum Pharmaceuticals annual EBITDA?
The current annual EBITDA of MIRM is -$48.97M
What is the all time high annual EBITDA for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high annual EBITDA is -$48.97M
What is Mirum Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, MIRM annual EBITDA has changed by +$87.52M (+64.12%)
What is Mirum Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of MIRM is -$4.00M
What is the all time high quarterly EBITDA for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high quarterly EBITDA is $61.38M
What is Mirum Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, MIRM quarterly EBITDA has changed by +$11.41M (+74.05%)
What is Mirum Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of MIRM is -$37.56M
What is the all time high TTM EBITDA for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high TTM EBITDA is -$65.00K
What is Mirum Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, MIRM TTM EBITDA has changed by +$90.00M (+70.56%)